small snippet Wilson HTM set to close books on Anatara IPO...

small snippet

Wilson HTM set to close books on Anatara IPO

PUBLISHED: 27 Aug 2014 15:13:52  | UPDATED: 28 Aug 2014 06:03:18
Edited by Sarah Thompson, Anthony Macdonald and Gretchen Friemann
Share Links: email
Wilson HTM Corporate Finance is calling for bids into Anatara Lifesciences’ initial public offering ahead of the 4pm Wednesday close.
Anatara, which is an ASX-hopeful with a treatment for diarrhoea in pigs, is seeking to raise $7 million through the sale of 14 million shares at 50¢ each. If successful, it would list with a $18.9 million market capitalisation on October 10.
According to a termsheet sent to sophisticated investors, Anatara is seeking the funds to progress its Detach product in Australia, Europe and the United States of America.
The company is expected to lodge a prospectus with the corporate regulator on August 29.
Anatara is chaired by Dr Melvyn Bridges, who is also currently a director at technical testing business ALS Limited and Tissue Therapies.